Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:e23
Published online before print April 26, 2007, doi: 10.1161/STROKEAHA.106.479444
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/e23    most recent
STROKEAHA.106.479444v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grond-Ginsbach, C.
Right arrow Articles by Pezzini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grond-Ginsbach, C.
Right arrow Articles by Pezzini, A.

(Stroke. 2007;38:e23.)
© 2007 American Heart Association, Inc.


Letters to the Editor

GPx-3 Gene Promoter Variation and the Risk of Arterial Ischemic Stroke

Caspar Grond-Ginsbach, PhD Christoph Lichy, MD

Neurology Department, University of Heidelberg, Heidelberg, Germany

Alessandro Padovani, MD Alessandro Pezzini, MD

Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

The recently published association of a particular promoter variant of the GPx-3 (plasma glutathione peroxidase) gene with increased risk for arterial ischemic stroke in this journal1 was the result of a long-duration research project. A set of linked polymorphisms in the promotor of the GPx-3 gene was described previously, and it was shown that carriers of a particular haplotype (H2) had a 2-fold increase in risk of ischemic stroke compared with noncarriers.2 The authors had, furthermore, analyzed the regulation of GPx-3 expression in a cultured cell system, identified a novel transcription start site and demonstrated that hypoxia was a strong transcriptional regulator of GPx-3 expression.3 The interest of the research group in GPx-3 was raised by their initial discovery of decreased plasma glutathione peroxidase activity in familial childhood stroke.4

The novel investigations extended these findings in several ways: 8 single nucleotide polymorphisms (SNP) were identified in the 5'end flanking region as well as 8 promoter haplotypes. The association of the H2 haplotype with an increased risk of arterial ischemic stroke (AIS) was demonstrated in an enlarged series of 123 young adults, compared with 123 control subjects. The association was confirmed in a second independent population with childhood stroke (82 patients and 82 control subjects).1

These promising results lead us to analyze the GPx-3 promoter in 2 populations of young stroke patients (<50 years) in order to confirm these results in a replica study. The H2 haplotype was tagged with the –65 T/C SNP as well as . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
C. Grond-Ginsbach, M.-L. Arnold, C. Lichy, A. Grau, and K. Reuner
No Association of the Plasma Glutathione Peroxidase (GPx-3) Gene With Cerebral Venous Thrombosis in the German Population
Stroke, February 1, 2009; 40(2): e24 - e24.
[Full Text] [PDF]